IBM entered DARPA Stage C while IBM stock sits 29.26 percent below its high
IBM entered DARPA Stage C while IBM stock sits 29.26 percent below its high ad-hoc-news.de
Covered in this story
Analyst targets on IBM
- UBS: $231 → $236 by Oct 2027 · Neutral via Investing.com
- Truist Securities: $227 → $240 by Oct 2027 via Pluang
- Barclays: $234 → $350 by Aug 2027 · Overweight via foreignpolicyjournal.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $IBM yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on IBM →Dalsna Finance is currently tracking 49 stories mentioning IBM, the earliest published 20 Jul 2026.
Summary aggregated from ad-hoc-news.de's public RSS feed. The full reporting belongs to ad-hoc-news.de — please read it on their site.